CD4+FoxP3+ regulatory T-cells in human systemic lupus erythematosus

Journal of the Formosan Medical Association

Volumn 111, Issue 9, 2012, Pages 465-470

  Suen, Jau Ling ^a,b   Chiang, Bor Luen ^c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

FoxP3; Regulatory T cell; Systemic lupus erythematosus

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ADAPTIVE IMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL THERAPY; HUMAN; IMMUNOTHERAPY; INNATE IMMUNITY; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIGENS, CD4; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; T-LYMPHOCYTES, REGULATORY;

EID: 84867012608     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/j.jfma.2012.05.013     Document Type: Review

References (46)

1. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005, 6:345-352.
2. Baecher-Allan C., Brown J.A., Freeman G.J., Hafler D.A. CD4+CD25high regulatory cells in human peripheral blood. J Immunol 2001, 167:1245-1253.
3. Liu W., Putnam A.L., Xu-Yu Z., Szot G.L., Lee M.R., Zhu S., et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4 + T reg cells. J Exp Med 2006, 203:1701-1711.
4. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
5. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003, 4:330-336.
6. Seddiki N., Santner-Nanan B., Martinson J., Zaunders J., Sasson S., Landay A., et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006, 203:1693-1700.
7. Miyara M., Yoshioka Y., Kitoh A., Shima T., Wing K., Niwa A., et al. Functional delineation and differentiation dynamics of human CD4 + T cells expressing the FoxP3 transcription factor. Immunity 2009, 30:899-911.
8. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001, 27:68-73.
9. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., Rudensky A.Y. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005, 22:329-341.
10. Khattri R., Cox T., Yasayko S.A., Ramsdell F. An essential role for Scurfin in CD4+CD25 + T regulatory cells. Nat Immunol 2003, 4:337-342.
11. Wildin R.S., Ramsdell F., Peake J., Faravelli F., Casanova J.L., Buist N., et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001, 27:18-20.
12. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001, 27:20-21.
13. Walker M.R., Kasprowicz D.J., Gersuk V.H., Benard A., Van Landeghen M., Buckner J.H., et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25 - T cells. J Clin Invest 2003, 112:1437-1443.
14. Allan S.E., Passerini L., Bacchetta R., Crellin N., Dai M., Orban P.C., et al. The role of 2 FOXP3 isoforms in the generation of human CD4 + Tregs. J Clin Invest 2005, 115:3276-3284.
15. Gavin M.A., Torgerson T.R., Houston E., DeRoos P., Ho W.Y., Stray-Pedersen A., et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci U S A 2006, 103:6659-6664.
16. Shimizu J., Yamazaki S., Takahashi T., Ishida Y., Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002, 3:135-142.
17. Ito T., Hanabuchi S., Wang Y.H., Park W.R., Arima K., Bover L., et al. Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity 2008, 28:870-880.
18. Lohr J., Knoechel B., Abbas A.K. Regulatory T cells in the periphery. Immunol Rev 2006, 212:149-162.
19. Kretschmer K., Apostolou I., Hawiger D., Khazaie K., Nussenzweig M.C., von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 2005, 6:1219-1227.
20. Rutella S., Danese S., Leone G. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 2006, 108:1435-1440.
21. Sun C.M., Hall J.A., Blank R.B., Bouladoux N., Oukka M., Mora J.R., et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 2007, 204:1775-1785.
22. Kyttaris V.C., Juang Y.T., Tsokos G.C. Immune cells and cytokines in systemic lupus erythematosus: an update. Curr Opin Rheumatol 2005, 17:518-522.
23. Bagavant H., Tung K.S. Failure of CD25 + T cells from lupus-prone mice to suppress lupus glomerulonephritis and sialoadenitis. J Immunol 2005, 175:944-950.
24. Scalapino K.J., Tang Q., Bluestone J.A., Bonyhadi M.L., Daikh D.I. Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J Immunol 2006, 177:1451-1459.
25. Zheng S.G., Wang J.H., Koss M.N., Quismorio F., Gray J.D., Horwitz D.A. CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-beta suppress a stimulatory graft-versus-host disease with a lupus-like syndrome. J Immunol 2004, 172:1531-1539.
26. Crispin J.C., Martinez A., Alcocer-Varela J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 2003, 21:273-276.
27. Liu M.F., Wang C.R., Fung L.L., Wu C.R. Decreased CD4+CD25 + T cells in peripheral blood of patients with systemic lupus erythematosus. Scand J Immunol 2004, 59:198-202.
28. Lee J.H., Wang L.C., Lin Y.T., Yang Y.H., Lin D.T., Chiang B.L. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Immunology 2006, 117:280-286.
29. Miyara M., Amoura Z., Parizot C., Badoual C., Dorgham K., Trad S., et al. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 2005, 175:8392-8400.
30. Valencia X., Yarboro C., Illei G., Lipsky P.E. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 2007, 178:2579-2588.
31. Alvarado-Sanchez B., Hernandez-Castro B., Portales-Perez D., Baranda L., Layseca-Espinosa E., Abud-Mendoza C., et al. Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 2006.
32. Suen J.L., Li H.T., Jong Y.J., Chiang B.L., Yen J.H. Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus. Immunology 2009, 127:196-205.
33. Lin S.C., Chen K.H., Lin C.H., Kuo C.C., Ling Q.D., Chan C.H. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Eur J Clin Invest 2007, 37:987-996.
34. Yan B., Ye S., Chen G., Kuang M., Shen N., Chen S. Dysfunctional CD4+, CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Arthritis Rheum 2008, 58:801-812.
35. Zhang B., Zhang X., Tang F.L., Zhu L.P., Liu Y., Lipsky P.E. Clinical significance of increased CD4+CD25-Foxp3 + T cells in patients with new-onset systemic lupus erythematosus. Ann Rheum Dis 2008, 67:1037-1040.
36. Suen J.L., Chuang Y.H., Tsai B.Y., Yau P.M., Chiang B.L. Treatment of murine lupus using nucleosomal T cell epitopes identified by bone marrow-derived dendritic cells. Arthritis Rheum 2004, 50:3250-3259.
37. Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003, 198:1875-1886.
38. Franz B., Fritzsching B., Riehl A., Oberle N., Klemke C.D., Sykora J., et al. Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus. Arthritis Rheum 2007, 56:1910-1920.
39. Tzeng T.C., Suen J.L., Chiang B.L. Dendritic cells pulsed with apoptotic cells activate self-reactive T-cells of lupus mice both in vitro and in vivo. Rheumatology (Oxford) 2006, 45:1230-1237.
40. Blanco P., Palucka A.K., Gill M., Pascual V., Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001, 294:1540-1543.
41. Wan S., Xia C., Morel L. IL-6 produced by dendritic cells from lupus-prone mice inhibits CD4+CD25 + T cell regulatory functions. J Immunol 2007, 178:271-279.
42. Hahn B.H., Anderson M., Le E., La Cava A. Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients. Arthritis Rheum 2008, 58:2488-2497.
43. Sagoo P., Lombardi G., Lechler R.I. Regulatory T cells as therapeutic cells. Curr Opin Organ Transplant 2008, 13:645-653.
44. Strauss L., Czystowska M., Szajnik M., Mandapathil M., Whiteside T.L. Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin. PLoS One 2009, 4. e5994.
45. Trzonkowski P., Bieniaszewska M., Juscinska J., Dobyszuk A., Krzystyniak A., Marek N., et al. First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127 - T regulatory cells. Clin Immunol 2009, 133:22-26.
46. Tao R., de Zoeten E.F., Ozkaynak E., Chen C., Wang L., Porrett P.M., et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med 2007, 13:1299-1307.